James Treco serves as Executive at Tonix Pharmaceuticals Holding Corp., where they oversee executive responsibilities. Since joining the company, James Treco has executed 3 insider transactions totaling $18.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 20, 2025 involved purchasing 250 shares valued at $9.0K.
James Treco currently holds 250 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Treco has been a net buyer of TNXP stock. They have purchased $18.7K and sold $0 worth of shares.
James Treco's most recent insider trade was on Aug 20, 2025, when they purchased 250 shares at $36.00 per share.
Get notified when new Form 4 filings are submitted
| $0.89 |
| Discretionary |
| Aug 14, 2020 | TNXP | $4.8K | Purchase | 4,500 | $1.06 | Discretionary |